The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules
Inngår i serie: NBER working paper series (5717)
Bok Engelsk utgitt 1996
Bok Engelsk utgitt 1996
Ledig
- Automatlager: 1 av 1 ledig
*001872275 *00520250613174146.0 *007ta *008020429s1996 xxu 000 u eng d *00900747cam a22002057c 4500 *019 $bl *035 $a(EXLNZ-47BIBSYS_NETWORK)990209510944702201 *035 $a(NO-LaBS)14076909(bibid) *035 $a(NO-TrBIB)020951094 *035 $a020951094-47bibsys_network *040 $aNO-TrBIB$bnob$ekatreg *24504$aThe strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules *260 $aWashington, D.C.$bNBER$c1996 *300 $a38 s. *4901 $aNBER working paper series$v5717 *7001 $aMorton, Fiona M. Scott$_30208400 *7102 $aNational Bureau of Economic Research (Forente Stater)$_13074800 *830 0$aWorking paper series (National Bureau of Economic Research : trykt utg.)$x0898-2937$v5717$w999105437124702201$_13074900 *901 $a60 *999 $aoai:nb.bibsys.no:990209510944702202$b2021-11-14T20:55:36Z$z990209510944702202 ^